Long-term benefit of direct-acting antivirals on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection

被引：0
|
作者：
Chuaypen, Natthaya [1 ]
Jinato, Thananya [1 ]
Tangkijvanich, Pisit [1 ]
机构：
[1] Chulalongkorn Univ, Fac Med, Biochem, Bangkok, Thailand
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-243
引用
收藏
页码：S354 / S355
页数：2
相关论文
共 50 条
  • [1] Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection
    Natthaya Chuaypen
    Thananya Jinato
    Anchalee Avihingsanon
    Intawat Nookaew
    Yasuhito Tanaka
    Pisit Tangkijvanich
    Scientific Reports, 13
  • [2] Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection
    Chuaypen, Natthaya
    Jinato, Thananya
    Avihingsanon, Anchalee
    Nookaew, Intawat
    Tanaka, Yasuhito
    Tangkijvanich, Pisit
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
    Gambato, Martina
    Manuli, Chiara
    Lynch, Erica N.
    Battistella, Sara
    Germani, Giacomo
    Senzolo, Marco
    Zanetto, Alberto
    Ferrarese, Alberto
    Vitale, Alessandro
    Gringeri, Enrico
    Cillo, Umberto
    Burra, Patrizia
    Russo, Francesco Paolo
    VIRUSES-BASEL, 2023, 15 (08):
  • [4] Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients
    Lattanzi, Barbara
    Baroncelli, Silvia
    De Santis, Adriano
    Galluzzo, Clementina Maria
    Mennini, Gianluca
    Michelini, Zuleika
    Lupo, Marinella
    Corradini, Stefano Ginanni
    Rossi, Massimo
    Palmisano, Lucia
    Merli, Manuela
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1146 - 1155
  • [5] Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people
    Brzdek, Michal
    Zarebska-Michaluk, Dorota
    Tomasiewicz, Krzysztof
    Tudrujek-Zdunek, Magdalena
    Lorenc, Beata
    Mazur, Wlodzimierz
    Berak, Hanna
    Janocha-Litwin, Justyna
    Klapaczynski, Jakub
    Sitko, Marek
    Janczewska, Ewa
    Dybowska, Dorota
    Parfieniuk-kowerda, Anna
    Piekarska, Anna
    Jaroszewicz, Jerzy
    Flisiak, Robert
    MINERVA MEDICA, 2024, : 266 - 276
  • [6] HCV-infected solid organ donors, direct-acting antivirals and the current challenges
    Fabrizi, Fabrizio
    Cerutti, Roberta
    Silva, Marcelo
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (01) : 7 - 14
  • [7] Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy
    Pontali, Emanuele
    Fiore, Vito
    Ialungo, Anna Maria
    Ranieri, Roberto
    Mollaretti, Oscar
    Barbarini, Giorgio
    Marri, Daniele
    Prestileo, Tullio
    Dell'Isola, Serena
    Rastrelli, Elena
    Leo, Guido
    Starnini, Giulio
    Babudieri, Sergio
    Madeddu, Giordano
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 59 : 50 - 53
  • [8] Reversal of T cell exhaustion in chronic HCV-infected patients receiving direct-acting antivirals
    Burchill, Matthew A.
    Golden-Mason, Lucy
    Rosen, Hugo R.
    HEPATOLOGY, 2014, 60 : 311A - 311A
  • [9] Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals
    Musolino, Cristina
    Cacciola, Irene
    Tripodi, Gianluca
    Lombardo, Daniele
    Raffa, Giuseppina
    Alibrandi, Angela
    Squadrito, Giovanni
    Raimondo, Giovanni
    Pollicino, Teresa
    ANTIVIRAL THERAPY, 2019, 24 (03) : 187 - 192
  • [10] Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
    El Badry, Mohamed Mohei
    Ali, Doaa Abdelhady
    Eltaweel, Noha Hamdy
    Abdel-Wahed, Marwa A.
    EGYPTIAN LIVER JOURNAL, 2020, 10 (01)
12345